Psyence Biomedical Ltd. SEC filings PBM
Psyence Biomedical Ltd. has 170 filings in SEC EDGAR's recent list, going back to Aug 1, 2023. Its latest annual report, Form 20-F, was filed on Jun 22, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jun 22, 2026 | Mar 31, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Jul 25, 2025 | Mar 31, 2025 |
| 20-F | Annual report (foreign issuer) | Jun 25, 2025 | Mar 31, 2025 |
| 20-F | Annual report (foreign issuer) | Jul 29, 2024 | Mar 31, 2024 |
| 20-F | Annual report (foreign issuer) | Jan 31, 2024 | Jan 25, 2024 |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBM (Nasdaq), PBMWW (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1985062
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.